Skip to content

REPL

Replimune Group, Inc.

NASDAQ · Healthcare · Biotechnology · US

$15.04
−1.64%
Ask drillr
2
Insider buys (3m)
5
Insider sells (3m)
-$1.0M
Net value (3m)
+58.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 19, 2026Hill Emily Luisa · officer: Chief Financial OfficerSale9,256$14
Aug 12, 2026Xynos Konstantinos · officer: Chief Medical OfficerSale11,447$13
Aug 12, 2026Patel Sushil · director, officer: Chief Executive OfficerSale39,341$13
Aug 12, 2026Hill Emily Luisa · officer: Chief Financial OfficerSale11,448$13
Aug 12, 2026Schwendenman Andrew · officer: Chief Accounting OfficerSale7,632$13
Aug 11, 2026BAKER BROS. ADVISORS LP · director, 10 percent owner: Purchase126,394$0.00
Aug 11, 2026BAKER BROS. ADVISORS LP · director, 10 percent owner: Purchase2,609,946$0.00
Jun 3, 2026Sarchi Christopher · officer: Chief Commercial OfficerSale12,000$9.24
May 20, 2026Xynos Konstantinos · officer: Chief Medical OfficerSale14,023$5.08
May 20, 2026Hill Emily Luisa · officer: Chief Financial OfficerSale7,812$5.08
May 20, 2026Schwendenman Andrew · officer: Chief Accounting OfficerSale7,894$5.08
May 20, 2026Astley-Sparke Philip · directorSale17,657$5.08
May 20, 2026Patel Sushil · director, officer: Chief Executive OfficerSale37,324$5.08
May 20, 2026Sarchi Christopher · officer: Chief Commercial OfficerSale8,626$5.08
Apr 7, 2026Hill Emily Luisa · officer: Chief Financial OfficerA-Award75,000$7.61
Apr 7, 2026Astley-Sparke Philip · directorA-Award75,000$7.61
Apr 7, 2026BAKER BROS. ADVISORS LP · director, 10 percent owner: A-Award44,500$7.61
Apr 7, 2026Schwendenman Andrew · officer: Chief Accounting OfficerA-Award55,000$7.61
Apr 7, 2026Xynos Konstantinos · officer: Chief Medical OfficerA-Award75,000$7.61
Apr 7, 2026Weinand Dieter · directorA-Award44,500$7.61
Apr 7, 2026Balachandran Madhavan · directorA-Award44,500$7.61
Apr 7, 2026Pucci Paolo · directorA-Award44,500$7.61
Apr 7, 2026Xynos Konstantinos · officer: Chief Medical OfficerA-Award50,000$0.00
Apr 7, 2026Dhingra Kapil · directorA-Award44,500$7.61
Apr 7, 2026Oliger Christy J. · directorA-Award44,500$7.61
Apr 7, 2026Astley-Sparke Philip · directorA-Award50,000$0.00
Apr 7, 2026Peeples-Dyer Veleka · directorA-Award44,500$7.61
Apr 7, 2026Hill Emily Luisa · officer: Chief Financial OfficerA-Award50,000$0.00
Apr 7, 2026Patel Sushil · director, officer: Chief Executive OfficerA-Award376,860$7.61
Apr 7, 2026Sarchi Christopher · officer: Chief Commercial OfficerA-Award75,000$7.61
Institutional positioning

13F filings over the trailing two quarters

New 120Increased 138Reduced 101Sold out 56
FilerActionSharesFiled
BAKER BROS. ADVISORS LPUnchanged11,045,336May 15, 2026
BAKER BROS. ADVISORS LPUnchanged11,045,336Aug 14, 2026
BlackRock, Inc.Increased8,958,535Aug 7, 2026
PRICE T ROWE ASSOCIATES INC /MD/Reduced8,121,433May 15, 2026
RTW INVESTMENTS, LPIncreased7,411,581Aug 14, 2026
RTW INVESTMENTS, LPIncreased7,356,916May 15, 2026
Ridgeback Capital Investments L.P.New Position7,310,656Aug 14, 2026
BLACKROCK, INC.Increased6,239,239May 13, 2026
GOLDMAN SACHS GROUP INCIncreased4,551,018Aug 14, 2026
STATE STREET CORPIncreased4,440,144Aug 7, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCIncreased4,389,836Aug 14, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCIncreased4,221,836May 15, 2026
Boxer Capital Management, LLCIncreased3,983,000Aug 14, 2026
Caption Management, LLCIncreased3,957,773Aug 14, 2026
STATE STREET CORPIncreased3,782,237May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 19, 2026